Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/12312
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lertjirachai I. | |
dc.contributor.author | Wood E.H. | |
dc.contributor.author | Moinuddin O. | |
dc.contributor.author | Drenser K.A. | |
dc.date.accessioned | 2021-04-05T03:02:45Z | - |
dc.date.available | 2021-04-05T03:02:45Z | - |
dc.date.issued | 2019 | |
dc.identifier.issn | 24519936 | |
dc.identifier.other | 2-s2.0-85065230637 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/12312 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065230637&doi=10.1016%2fj.ajoc.2019.100458&partnerID=40&md5=9dfce71d0c9831b749be5c2ef2082eae | |
dc.description.abstract | Purpose: To report case of Coats disease with the longest known interval of disease quiescence prior to first reactivation (17 years). Observation: A 25-year-old male was regularly followed for Coats disease since age 4. After initial treatment with cryoablation, disease quiescence was achieved at age 8. The disease activity was well controlled for 17 years after which he developed decreased vision in the right eye at age 25. Late reactivation of Coats disease was diagnosed and multiple treatments ensued. Despite aggressive therapy, the patient experienced progressive exudation warranting surgical management and eventually developed neovascular glaucoma. Conclusion: Once diagnosed with Coats disease, lifelong monitoring is essential to early detection and treatment of potential disease reactivation. The interval between disease quiescence and reactivation is variable, with this case representing the longest known interval of disease quiescence prior to first reactivation (17 years). © 2019 The Authors | |
dc.subject | antiglaucoma agent | |
dc.subject | ranibizumab | |
dc.subject | steroid | |
dc.subject | triamcinolone acetonide | |
dc.subject | vasculotropin | |
dc.subject | vasculotropin antibody | |
dc.subject | adult | |
dc.subject | Article | |
dc.subject | B scan | |
dc.subject | best corrected visual acuity | |
dc.subject | case report | |
dc.subject | clinical article | |
dc.subject | cryoablation | |
dc.subject | disease course | |
dc.subject | disease exacerbation | |
dc.subject | exudative retinitis | |
dc.subject | follow up | |
dc.subject | human | |
dc.subject | intraocular pressure | |
dc.subject | lensectomy | |
dc.subject | male | |
dc.subject | neovascular glaucoma | |
dc.subject | optical coherence tomography | |
dc.subject | pars plana vitrectomy | |
dc.subject | recurrent disease | |
dc.subject | retina detachment | |
dc.subject | retina fluorescein angiography | |
dc.subject | subcapsular cataract | |
dc.subject | subtenon drug administration | |
dc.title | Late re-activation of Coats disease | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | American Journal of Ophthalmology Case Reports. Vol 15, (2019) | |
dc.identifier.doi | 10.1016/j.ajoc.2019.100458 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.